SCHEMBL5539009

SCHEMBL5539009

O=C(NCCCN1CCCC1=O)c1c(O)c2ncc(Cc3ccc(F)cc3)cc2n(Cc2ccncc2)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
GAA P10253 3/20 0.42
RXFP1 Q9HBX9 1/20 0.42
TYRO3 Q06418 2/20 0.41
KDM4E B2RXH2 4/20 0.41
LMNA P02545 1/20 0.41
HSD17B10 Q99714 3/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPT P10636 1/20 0.40
FLT1 P17948 1/20 0.40
FLT4 P35916 1/20 0.40
KDR P35968 1/20 0.40
TGFBR1 P36897 1/20 0.40
MAPK8 P45983 1/20 0.40
MAPK9 P45984 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5538441 0.92 ALDH1A1 (0.49) ALDH1A1TSHRCYP2C19GAARXFP1
SCHEMBL5545520 0.92 KDM4E (0.43) ALDH1A1TSHRCYP2C19GAARXFP1
SCHEMBL5539930 0.91 CYP2C19 (0.46) ALDH1A1TSHRCYP2C19GAARXFP1
SCHEMBL5547092 0.91 CYP2C19 (0.46) ALDH1A1TSHRCYP2C19GAARXFP1
SCHEMBL5546009 0.90 CYP2C19 (0.46) ALDH1A1TSHRCYP2C19GAARXFP1
SCHEMBL5546453 0.90 CYP2C19 (0.48) ALDH1A1TSHRCYP2C19GAARXFP1
SCHEMBL5539125 0.90 CYP2C19 (0.45) ALDH1A1TSHRCYP2C19GAARXFP1
SCHEMBL5541025 0.89 CYP2C19 (0.45) ALDH1A1TSHRCYP2C19GAARXFP1
SCHEMBL5543248 0.89 CYP2C19 (0.45) ALDH1A1TSHRCYP2C19GAARXFP1
SCHEMBL15163636 0.89 ALDH1A1 (0.43) ALDH1A1TSHRCYP2C19GAARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150225399-A1 HIV INTEGRASE INHIBITORS VIIV HEALTHCARE CO (US) 2015-08-13 US disclosed
US-20140256713-A1 2-OXONAPHTHYRIDINE-3-CARBOXAMIDES HIV INTEGRASE INHIBITORS SHIONOGI & CO., LTD. (JP) 2014-09-11 US disclosed
EP-1720856-B1 HIV INTEGRASE INHIBITORS GLAXOSMITHKLINE LLC (US) 2013-08-14 EP disclosed
US-20070124152-A1 Hiv Integrase Inhibitors GLAXOSMITHKLINE LLC 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256713-A1 2-OXONAPHTHYRIDINE-3-CARBOXAMIDES HIV INTEGRASE INHIBITORS BCDIN3D, DUT, SAMHD1 ALDH1A1 3812/4885TSHR 4052/4885CYP2C19 2324/4885
US-20150225399-A1 HIV INTEGRASE INHIBITORS ING2, API5, SAMHD1 ALDH1A1 3073/4885TSHR 4622/4885CYP2C19 2455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.